Navigation Links
DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call
Date:1/31/2008

CUPERTINO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2007 financial results press release, you are invited to listen to the conference call that will be broadcast live over the Internet on Wednesday, February 6, 2008 at 9:00 a.m. EST (6:00 a.m. PST).

When: Wednesday, February 6, 2008 at 9:00 a.m. EST (6:00 a.m. PST).

Where: Live over the Internet -- Simply log on to http://www.durect.com,

and then click 'Investor Relations' and then 'Events Calendar.'

Webcast

Link: http://phx.corporate-ir.net/phoenix.zhtml?c=121590&p=irol-calendar

If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. DURECT to Host Webcast in Conjunction with an Analysts Day on October 17
2. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
3. Baxa Corporation Launches New Web Site
4. CuraGen Corporation Receives Notification from NASDAQ
5. Healionics Corporation Completes Series A Financing
6. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
7. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
8. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
9. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
10. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
11. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , 22 de enero de 2015  El Dr. ... su llamada a nominaciones para 2015. Este prestigioso premio ... o tiene el potencial para hacer, contribuciones destacadas para ... aceptarán hasta el 15 de marzo de 2015 a ...
(Date:1/22/2015)... 2015  Derma Sciences, Inc. (Nasdaq: DSCI ... wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic ... to the Premier, Inc. Regenerative Skin Grafting contract ... AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue to ...
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... December 23, 2014 Earlier this year in ... director of the Adult Stem Cell Technology Center, LLC ( ... appreciated unique property of adult tissue stem cells. His ... Past, Important for the Future,” embodied the essence of his ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... N.J. , Jan. 27 Covance Inc. (NYSE: ... 31, 2009 of $0.64 per diluted share.  For the ... inclusive of $0.10 per share in gains related to sales ... the third quarter.  Excluding the gains on sales and the tax item, ...
... ... leaders at Biomanufacturing Summit in La Jolla, California January 26th and 27th, 2010. ... Fort Collins, CO ... InVitria’s products enable its customers to optimize their biomanufacturing process from the cell bank ...
... , , , , ... January 27 Jubilant Biosys,Ltd., a subsidiary of Jubilant ... Pa. , U.S.A., announced today that they have,expanded their drug ... stage milestone. , The year-old partnership ...
Cached Biology Technology:Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 2Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 3Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 4Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 5Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 6Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 7Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 8Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 9Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 10Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 11Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 12Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 13Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 14Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 15Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 16Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share 17InVitria Sponsors 2010 Biomanufacturing Summit 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 3
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... commerce market, reports on the recent success of the Wocket™ smart wallet ... Wocket smart wallet was named as one of the "11 Hot ... "5 Best Products Launched At CES So Far" by Newseveryday.com and "The ...
(Date:1/22/2015)... , Jan. 22, 2015   EyeLock, Inc. , a ... has appointed Steve Gerber to the new role ... be responsible for leading development of mobile platforms and wearable ... of success and innovation in the semiconductor industry to his ...
(Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... mother,s diet may be able to interact with the genes ... of birth defect according to research funded by the Wellcome ... in the journal Human Molecular Genetics , suggests that ... pregnancy could be inadvertently putting the health of their offspring ...
... mechanism by which a herpes virus invades cells has remained ... viruses. New research funded by the National Institutes of Health ... Structural & Molecular Biology reveals the unusual structure of ... cells. This detailed map of a key piece of the ...
... 6, 2010 Investigators at the Translational Genomics Research Institute ... patients who no longer respond to conventional chemotherapy. A ... of the journal Gynecologic Oncology describes how the ... to incorporate into therapies for women with ovarian cancer. ...
Cached Biology News:Maternal diet and genes interact to affect heart development 2Maternal diet and genes interact to affect heart development 3Map of herpes virus protein suggests a new drug therapy 2TGen finds protein inhibitor revives chemotherapy for ovarian patients 2TGen finds protein inhibitor revives chemotherapy for ovarian patients 3
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Rabbit polyclonal to Oct2, prediluted ( Abpromise for all tested applications). entrezGeneID: 5452 SwissProtID: P09086...
Anti-Mouse Reticular Fibroblast, Purified (Clone ER-TR7) (rat IgG2a)...
Mouse monoclonal [2Q2147] to Aequorin ( Abpromise for all tested applications)....
Biology Products: